John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
FIGS
FIGS
$2.43B
| $3.53M | 0.01% |
769,037
+335,605
| +77% | +$1.78M |
|
1277
Nabors Industries
NBR
$1.3B
| $3.53M | 0.01% |
84,605
-6,081
| -7% | -$310K |
|
1278
Capital One
COF
$133B
| $3.51M | 0.01% |
19,562
-2,551
| -12% | -$482K |
|
1279
JPMorgan Chase
JPM
$945B
| $3.51M | 0.01% |
14,295
+95
| +0.7% | +$24.2K |
|
1280
California Resources
CRC
$4.63B
| $3.5M | 0.01% |
79,605
+6,278
| +9% | +$298K |
|
|
ACH
1281
Accendra Health
ACH
$84.6M
| $3.5M | 0.01% |
387,245
+324,304
| +515% | +$3.42M |
|
1282
HCA Healthcare
HCA
$92.7B
| $3.49M | 0.01% |
10,100
-457,337
| -98% | -$147M |
|
|
BSII
1283
DELISTED
Black Spade Acquisition II Co Class A Ordinary Share
BSII
| $3.49M | 0.01% |
343,750
| – | – |
|
1284
IBEX
IBEX
$493M
| $3.48M | 0.01% |
142,961
+27,146
| +23% | +$651K |
|
1285
Woodward
WWD
$19.9B
| $3.48M | 0.01% |
19,070
-191,144
| -91% | -$35.3M |
|
1286
Tenet Healthcare
THC
$22B
| $3.48M | 0.01% |
25,850
-232,093
| -90% | -$30.6M |
|
1287
GSK
GSK
$104B
| $3.47M | 0.01% |
89,500
-485,254
| -84% | -$17.8M |
|
1288
McEwen Inc
MUX
$1.3B
| $3.47M | 0.01% |
459,074
-56,396
| -11% | -$440K |
|
1289
lululemon athletica
LULU
$13.4B
| $3.46M | 0.01% |
12,240
+834
| +7% | +$306K |
|
1290
Weave Communications
WEAV
$583M
| $3.46M | 0.01% |
312,386
-342,042
| -52% | -$4.91M |
|
1291
PENN Entertainment
PENN
$2.44B
| $3.46M | 0.01% |
212,252
+189,920
| +850% | +$3.71M |
|
1292
Incyte
INCY
$26.4B
| $3.45M | 0.01% |
56,985
+28,936
| +103% | +$2.02M |
|
1293
Zimmer Biomet
ZBH
$19.1B
| $3.44M | 0.01% |
30,400
-8,275
| -21% | -$885K |
|
1294
CION Investment
CION
$371M
| $3.44M | 0.01% |
332,417
-58,155
| -15% | -$674K |
|
1295
Coursera
COUR
$1.63B
| $3.44M | 0.01% |
516,382
-508,284
| -50% | -$4.04M |
|
1296
CrowdStrike
CRWD
$189B
| $3.42M | 0.01% |
38,800
-12,000
| -24% | -$1.14M |
|
1297
MGE Energy Inc
MGEE
$2.99B
| $3.42M | 0.01% |
36,744
+5,160
| +16% | +$470K |
|
1298
Kyndryl
KD
$2.79B
| $3.4M | 0.01% |
108,377
-83,112
| -43% | -$3.11M |
|
1299
Genco Shipping & Trading
GNK
$1.16B
| $3.4M | 0.01% |
254,388
-318,380
| -56% | -$4.51M |
|
|
MPT
1300
Medical Properties Trust
MPT
$2.45B
| $3.39M | 0.01% |
562,600
-68,100
| -11% | -$344K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.